Remote Vital Sign Monitoring in Palliative Care Patients Using a Wearable ECG Monitor

Condition(s) studied

Study summary

The goal of this study is the assess the use of remote monitoring of vital signs using commercially available medical devices in patients with advanced cancer admitted to a hospice inpatient unit for end-of-life care.

The objectives of the study are:

1. could remote monitoring of vital signs improve patient care through the earlier identification of infections and other (potentially reversible) problems;
2. could remote monitoring of vital signs improve the accuracy of our estimates about how long a person has to live; and c) determine the relationship between complaints of pain / other symptoms and vital signs.

Eligibility

Primary outcome measure(s)

• Mean, standard deviation, median, and range of heart rate variability (HRV) at predefined time intervals prior to death — From device initiation until death (up to 14 days), with analysis conducted across predefined time intervals prior to death
  Summary statistics (mean, standard deviation, median, and range) of heart rate variability defined as the Root Mean Square of Successive Differences (RMSSD), measured using a wearable ECG patch at predefined time intervals prior to death (0-24 hours, 24-48 hours, 48-72 hours, 72 hours-7 days, and 7-14 days).

Trial sites (1)

More Our Lady's Hospice and Care Services trials in Ireland

Other trials for the same condition